TMEM132A and plasma cell myeloma: While there is a paucity of research investigating the effects of metformin on TMEM132A, a recent study reported that metformin treatment suppresses GRP78 to enhance apoptosis in multiple myeloma, suggesting this may be a mechanism by which metformin exerts its antineoplastic effects [19].